Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A122333-10mg | 10mg | In stock | $64.90 | |
A122333-50mg | 50mg | In stock | $129.90 | |
A122333-250mg | 250mg | In stock | $585.90 | |
A122333-1g | 1g | In stock | $2,106.90 | |
A122333-5g | 5g | In stock | $9,477.90 |
Potent AT1inverse agonist; antihypertensive
Synonyms | Azilsartan|147403-03-0|TAK-536|TAK 536|UNII-F9NUX55P23|F9NUX55P23|TAK536|CHEBI:68850|HSDB 8208|Azilsartan (TAK-536)|CHEMBL57242|DTXSID70163712|1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]- |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Potent angiotensin II type 1 (AT1) receptor inverse agonist (IC50= 2.6 nM at the human AT1receptor). Inhibits angiotensin II-induced IP1 accumulation in COS-7 cells; decreases maximal contraction of rabbit aortic strips in a concentration-dependent manner |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Type-1 angiotensin II receptor antagonist |
Note | 50mg、250mg、10mg卖完停产,不再备货 |
ALogP | 4.4 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488202872 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488202872 |
IUPAC Name | 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid |
INCHI | InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32) |
InChi Key | KGSXMPPBFPAXLY-UHFFFAOYSA-N |
Canonical SMILES | CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O |
Isomeric SMILES | CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O |
WGK Germany | 3 |
PubChem CID | 135415867 |
Molecular Weight | 456.45 |
PubChem SID | 488202872 |
---|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2428402 | Certificate of Analysis | Nov 22, 2023 | A122333 |
B2428401 | Certificate of Analysis | Nov 22, 2023 | A122333 |
B2428400 | Certificate of Analysis | Nov 22, 2023 | A122333 |
B2428399 | Certificate of Analysis | Nov 22, 2023 | A122333 |
J1908049 | Certificate of Analysis | Jul 07, 2023 | A122333 |
B23031072 | Certificate of Analysis | Feb 13, 2023 | A122333 |
B23031071 | Certificate of Analysis | Feb 13, 2023 | A122333 |
B23031070 | Certificate of Analysis | Feb 13, 2023 | A122333 |
B23031075 | Certificate of Analysis | Feb 08, 2023 | A122333 |
B23031073 | Certificate of Analysis | Feb 08, 2023 | A122333 |
I1819073 | Certificate of Analysis | Jul 21, 2022 | A122333 |
I1819072 | Certificate of Analysis | Jul 21, 2022 | A122333 |
I1424094 | Certificate of Analysis | Jul 19, 2022 | A122333 |
I1813160 | Certificate of Analysis | Jul 19, 2022 | A122333 |
E1406017 | Certificate of Analysis | Mar 29, 2022 | A122333 |
B23031089 | Certificate of Analysis | Feb 23, 2022 | A122333 |
B23031090 | Certificate of Analysis | Feb 23, 2022 | A122333 |
B2217320 | Certificate of Analysis | Feb 23, 2022 | A122333 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 45.65, Max Conc. mM: 100 |
---|---|
Sensitivity | Heat Sensitive |
Melt Point(°C) | 188 °C(dec.) |
Pictogram(s) | GHS08 |
---|---|
Signal | Danger |
Hazard Statements | H372:Causes damage to organs through prolonged or repeated exposure H360:May damage fertility or the unborn child H361:Suspected of damaging fertility or the unborn child H362:May cause harm to breast-fed children |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P270:Do not eat, drink or smoke when using this product. P263:Avoid contact during pregnancy/while nursing. P203:Obtain, read and follow all safety instructions before use. P318:if exposed or concerned, get medical advice. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |